Dr. Reddy’s has become the first company to take up drug discovery research in India (1993) and has led the industry from being- dubbed as ‘copycats’ for several years to now being acknowledged as ‘Innovators’. Dr. Reddy’s was listed on the New York Stock Exchange – the first non-Japanese Asian pharmaceutical company to list on NYSE – in April 2001 (RDY).

Dr. Reddy is a serving member of the Prime Minister’s Council on Trade & Industry, Government of India, and has been nominated to the Board of National Institute of Pharmaceutical Education and Research (NIPER). He is also a Member of the Board of Governors of Institute of Chemical Technology, University of Mumbai. Dr. Reddy chairs the Governing Body of Hyderabad Eye Research Foundation and also serves on the Board of Vision Research Foundation, Chennai.

Naandi Foundation, a not-for-profit development institution that strives for eradication of poverty has Dr. Reddy as its founding father. He is also founder-Chairman of Dr. Reddy’s Foundation for Human & Social Development, a social arm of Dr. Reddy’s, which acts as a catalyst of change to achieve sustainable development.

Dr. Reddy has been the recipient of several awards and honors. Notable among them are the Sir PC Ray award, twice conferred on Dr. Reddy by Indian Chemical Manufacturers Association (1984, 1992) and the Federation of Asian Pharmaceutical Associations (FAPA)’s FAPA-Ishidate Award for Pharmaceutical Research in 1998. He was voted Businessman of the Year by India’s leading business magazine Business India in the year 2001. For his pioneering work and introduction of affordable medicine, CHEMTECH Foundation has bestowed on him the Achiever of the Year award in the year 2000 and the ‘Hall of Fame’ award in 2005, for his Entrepreneurship, Leadership and thrust on Innovation.